UBS OCONNOR LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,290,732
-36.6%
471,974
+63.1%
0.03%
-48.4%
Q2 2023$2,037,263
+5.2%
289,384
-29.1%
0.06%
+6.7%
Q1 2023$1,935,675
-99.9%
408,212
+101.2%
0.06%
+62.2%
Q3 2022$1,944,000,000
-31.5%
202,872
-21.0%
0.04%
-11.9%
Q2 2022$2,836,000,000256,8720.04%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders